Richard Adcock

Board Member

CEO

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Recorded roles and earnings-call appearances connecting this person to public companies.

IBRX

Current role

Board Member, CEO

2021-03-05–present

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2025	ImmunityBio, Inc. (IBRX)	President and CEO	$831,667	$141,684	$2,787,828	$8,353,406	$485,166	$117,202	$12,716,953
2024	ImmunityBio, Inc. (IBRX)	Chief Executive Officer and President	$802,123	—	$2,396,341	$7,214,767	$477,600	$64,044	$10,954,875
2023	ImmunityBio, Inc. (IBRX)	Chief Executive Officer and President	$796,000	$298,500	—	—	—	$62,403	$1,156,903
2022	ImmunityBio, Inc. (IBRX)	Chief Executive Officer and President	$790,760	—	—	$3,159,057	—	$58,690	$4,008,507
2021	ImmunityBio, Inc. (IBRX)	Chief Executive Officer and President	$765,144	$57,656	$13,872,641	$13,969,483	$269,063	$82,740	$29,016,727
2020	ImmunityBio, Inc. (IBRX)	Chief Executive Officer and President	$141,347	$67,808	—	—	—	$1,731	$210,886

No earnings-call appearances or filed executive changes recorded yet.